|
Market Closed -
NYSE
00:03:34 18/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 292.82 USD | -0.59% |
|
-0.36% | +28.15% |
| 12:31pm | Convatec shares rise as increases sales outlook as growth accelerates | AN |
| 11-18 | Merck stops trials of blood cancer drug after review of risks | RE |
| Market Cap | 518B 470B 434B 392B 739B 48,359B 768B 5,230B 2,069B 26,095B 1,942B 1,901B 82,448B | P/E 2026 * |
37.3x | P/E 2027 * | 27.5x |
|---|---|---|---|---|---|
| Enterprise Value | 581B 527B 487B 439B 830B 54,267B 861B 5,869B 2,321B 29,283B 2,179B 2,133B 92,519B | EV / Sales 2026 * |
8.57x | EV / Sales 2027 * | 7.73x |
| Free-Float |
95.51% | Yield 2026 * |
2.36% | Yield 2027 * | 2.48% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABBV | Delayed | |
| ABBV | Real-time | ||
| ABBV * | End-of-day quote | ||
| 4AB | Real-time | ||
| Real-time | |||
| 4AB | Real-time | ||
| 4AB | Delayed | ||
| 4AB | Delayed | ||
| 1ABBV | End-of-day quote | ||
| 4AB | Delayed | ||
| ABBV | Delayed | ||
| 0QCV | Delayed | ||
| ABBV | End-of-day quote | ||
| 0QCV | Real-time | ||
| ABBV | End-of-day quote | ||
| ABBVCL | End-of-day quote | ||
| ABBV | Delayed |
Last Transcript: AbbVie Inc.
| 1 day | +0.74% | ||
| 1 week | -0.36% | ||
| Current month | -0.70% | ||
| 1 month | +2.59% | ||
| 3 months | +16.97% | ||
| 6 months | +39.18% | ||
| Current year | +28.15% |
| 1 week | 291 | 301.2 | |
| 1 month | 278.01 | 302.93 | |
| Current year | 190.75 | 302.93 | |
| 1 year | 190.75 | 302.93 | |
| 3 years | 137.14 | 302.93 | |
| 5 years | 115.01 | 302.93 | |
| 10 years | 58.6 | 302.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Ed Rapp
BRD | Director/Board Member | 69 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 A | Free | Director | 59 | 0.0000% | ||
| 9/30/26 A | Free | Director | 129 | 0.0000% | ||
| 8/14/26 A | Exercice | Executive/Senior Manager | 98,130 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.59% | -0.36% | +25.14% | +111.73% | 518B | ||
| -1.13% | -1.17% | +38.55% | +139.23% | 1,261B | ||
| -1.36% | -0.74% | +39.64% | +86.06% | 671B | ||
| +0.06% | +1.02% | +32.38% | +71.20% | 387B | ||
| -0.75% | -3.16% | +54.39% | +40.90% | 353B | ||
| -0.43% | -0.11% | +30.00% | +57.33% | 300B | ||
| -0.62% | -1.47% | +0.93% | +35.48% | 283B | ||
| -0.95% | -1.57% | +34.01% | +72.55% | 248B | ||
| +1.60% | -0.36% | +37.21% | +125.66% | 211B | ||
| -0.25% | +0.64% | -9.97% | -60.97% | 179B | ||
| Average | -0.40% | +0.13% | +28.23% | +67.92% | 441B | |
| Weighted average by Cap. | -0.42% | -0.34% | +32.59% | +89.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.79B 61.54B 56.85B 51.29B 96.82B 6,334B 101B 685B 271B 3,418B 254B 249B 10,799B | 74.02B 67.2B 62.07B 56B 106B 6,916B 110B 748B 296B 3,732B 278B 272B 11,791B |
| Net income | 14.35B 13.03B 12.03B 10.86B 20.5B 1,341B 21.28B 145B 57.36B 724B 53.84B 52.71B 2,286B | 19.32B 17.54B 16.2B 14.61B 27.59B 1,805B 28.65B 195B 77.21B 974B 72.48B 70.95B 3,077B |
| Net Debt | 63.23B 57.4B 53.02B 47.83B 90.3B 5,907B 93.76B 639B 253B 3,188B 237B 232B 10,071B | 54.29B 49.28B 45.53B 41.07B 77.53B 5,072B 80.5B 549B 217B 2,737B 204B 199B 8,648B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | $292.82 | -0.59% | 3,950,014 |
| 16/11/26 | $294.55 | -0.16% | 5,493,798 |
| 13/11/26 | $295.03 | +0.20% | 3,262,103 |
| 12/11/26 | $294.45 | -0.18% | 4,826,816 |
| 11/11/26 | $294.98 | +0.37% | 3,262,250 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
















